Pisano Etta D, Acharyya Suddhasatta, Cole Elodia B, Marques Helga S, Yaffe Martin J, Blevins Meredith, Conant Emily F, Hendrick R Edward, Baum Janet K, Fajardo Laurie L, Jong Roberta A, Koomen Marcia A, Kuzmiak Cherie M, Lee Yeonhee, Pavic Dag, Yoon Sora C, Padungchaichote Wittaya, Gatsonis Constantine
Dept of Radiology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 4030 Bondurant Hall, Campus Box 7000, Chapel Hill, NC 27599-7515, USA.
Radiology. 2009 Aug;252(2):348-57. doi: 10.1148/radiol.2522081457.
To determine which factors contributed to the Digital Mammographic Imaging Screening Trial (DMIST) cancer detection results.
This project was HIPAA compliant and institutional review board approved. Seven radiologist readers reviewed the film hard-copy (screen-film) and digital mammograms in DMIST cancer cases and assessed the factors that contributed to lesion visibility on both types of images. Two multinomial logistic regression models were used to analyze the combined and condensed visibility ratings assigned by the readers to the paired digital and screen-film images.
Readers most frequently attributed differences in DMIST cancer visibility to variations in image contrast--not differences in positioning or compression--between digital and screen-film mammography. The odds of a cancer being more visible on a digital mammogram--rather than being equally visible on digital and screen-film mammograms--were significantly greater for women with dense breasts than for women with nondense breasts, even with the data adjusted for patient age, lesion type, and mammography system (odds ratio, 2.28; P < .0001). The odds of a cancer being more visible at digital mammography--rather than being equally visible at digital and screen-film mammography--were significantly greater for lesions imaged with the General Electric digital mammography system than for lesions imaged with the Fischer (P = .0070) and Fuji (P = .0070) devices.
The significantly better diagnostic accuracy of digital mammography, as compared with screen-film mammography, in women with dense breasts demonstrated in the DMIST was most likely attributable to differences in image contrast, which were most likely due to the inherent system performance improvements that are available with digital mammography. The authors conclude that the DMIST results were attributable primarily to differences in the display and acquisition characteristics of the mammography devices rather than to reader variability.
确定哪些因素对数字化乳腺摄影成像筛查试验(DMIST)的癌症检测结果有影响。
本项目符合健康保险流通与责任法案(HIPAA)要求,并获得了机构审查委员会的批准。七位放射科阅片医生对DMIST癌症病例中的胶片硬拷贝(屏-片)和数字化乳腺造影片进行了审查,并评估了两种类型图像上病变可见性的影响因素。使用两个多项逻辑回归模型来分析阅片医生对配对的数字化和屏-片图像给出的综合及简化后的可见性评级。
阅片医生最常将DMIST中癌症可见性的差异归因于数字化乳腺摄影与屏-片乳腺摄影之间图像对比度的变化,而非定位或压迫的差异。即使对患者年龄、病变类型和乳腺摄影系统进行了数据调整,乳房致密的女性的癌症在数字化乳腺造影片上比在数字化和屏-片乳腺造影片上同样可见的情况下更易见的几率,显著高于乳房不致密的女性(优势比,2.28;P <.0001)。与使用菲舍尔(P =.0070)和富士(P =.0070)设备成像的病变相比,使用通用电气数字化乳腺摄影系统成像的病变在数字化乳腺摄影时比在数字化和屏-片乳腺摄影时同样可见的情况下更易见的几率显著更高。
DMIST显示,与屏-片乳腺摄影相比,数字化乳腺摄影在乳房致密的女性中具有显著更高的诊断准确性,这很可能归因于图像对比度的差异,而这很可能是由于数字化乳腺摄影所具备固有的系统性能提升。作者得出结论,DMIST的结果主要归因于乳腺摄影设备的显示和采集特性差异,而非阅片者的变异性。